TREATING PATIENTS DIAGNOSED WITH PANCREATIC DUCT ADENOCARCINOMA WITH USING EPIDERMAL GROWTH FACTOR (EGFR) RECEPTOR MONOCLONAL ANTIBODIES

• 收藏
• 分享

专利权人:

发明人:

申请号：

RU2017142804

公开号：

RU2017142804A3

申请日:

申请国别(地区):

RU

年份:

2019

代理人:

摘要：

The present disclosure relates to the field of immunotherapy of cancer, in particular pancreatic ductal adenocarcinoma (PDAC). Means and methods for treatment of a population of PDAC patients suffering from PDAC tumours which express wildtype KRAS, HRAS or NRAS are disclosed. The claimed antibody is Nimotuzumab. The pancreatic cancer preferably does not contain KRAS mutations at position 12, 16, 61, 154.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/